In the latest session, Aldeyra Therapeutics Inc (NASDAQ: ALDX) closed at $4.15 up 16.90% from its previous closing price of $3.55. In other words, the price has increased by $+0.6000 from its previous closing price. On the day, 2288569 shares were traded.
Ratios:
For a deeper understanding of Aldeyra Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 03 ’24 when PERCEPTIVE ADVISORS LLC bought 309,847 shares for $4.09 per share. The transaction valued at 1,267,274 led to the insider holds 9,097,858 shares of the business.
PERCEPTIVE ADVISORS LLC bought 186,051 shares of ALDX for $640,015 on Apr 02 ’24. The 10% Owner now owns 8,788,011 shares after completing the transaction at $3.44 per share. On Apr 01 ’24, another insider, PERCEPTIVE ADVISORS LLC, who serves as the 10% Owner of the company, bought 8,374 shares for $3.25 each. As a result, the insider paid 27,216 and bolstered with 8,601,960 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALDX now has a Market Capitalization of 209.08M and an Enterprise Value of 81.91M.
Stock Price History:
The Beta on a monthly basis for ALDX is 1.51, which has changed by -58.04% over the last 52 weeks, in comparison to a change of 26.95% over the same period for the S&P500. Over the past 52 weeks, ALDX has reached a high of $11.97, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 3.3205, while the 200-Day Moving Average is calculated to be 4.7810.
Shares Statistics:
For the past three months, ALDX has traded an average of 499.58K shares per day and 617.6k over the past ten days. A total of 59.20M shares are outstanding, with a floating share count of 56.55M. Insiders hold about 3.98% of the company’s shares, while institutions hold 59.51% stake in the company. Shares short for ALDX as of Mar 15, 2024 were 1.83M with a Short Ratio of 3.66, compared to 1.93M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.10% and a Short% of Float of 3.94%.
Earnings Estimates
There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.12 for the current quarter, with a high estimate of $0.02 and a low estimate of -$0.21, while EPS last year was -$0.27. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.1 and low estimates of -$0.17.
Analysts are recommending an EPS of between $1.15 and -$0.72 for the fiscal current year, implying an average EPS of -$0.06. EPS for the following year is -$0.36, with 4 analysts recommending between $0.55 and -$0.8.
Revenue Estimates
Based on 4 analysts’ estimates, the company’s revenue will be $51.71M in the next fiscal year. The high estimate is $100M and the low estimate is $18.7M. The average revenue growth estimate for next year is up 29.90% from the average revenue estimate for this year.
